Dopamine induces apoptotic cell death of a catecholaminergic cell line derived from the central nervous system

Molecular Pharmacology

Volumn 50, Issue 5, 1996, Pages 1309-1315

  Masserano, Joseph M ^a   Gong, Li ^a   Kulaga, Henrietta ^a   Baker, Ivory ^a   Wyatt, Richard Jed ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADRENALIN; CATALASE; DOPAMINE; ISOPRENALINE; LEVODOPA; NORADRENALIN; OXIDOPAMINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOOXIDATION; CATECHOLAMINE NERVE CELL; CELL DEATH; CELL VIABILITY; DNA DEGRADATION; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CATECHOLAMINES; CELL DEATH; CENTRAL NERVOUS SYSTEM; DOPAMINE; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDES, ANTISENSE; PEROXIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0029826376     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Raff, M. C., B. A. Barres, J. F. Burne, H. S. Coles, Y. Ishizaki, and M. D. Jacobson. Programmed cell death and the control of cell survival: lessons from the nervous system. Science (Washington D. C.) 262:695-700 (1993).
2. MacManus, J. P., I. E. Hill, Z. G. Huang, I. Rasquinha, and E. Preston. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci. Lett. 164:89-92 (1993).
3. Pollard, H., S. Cantagrel, C. Charriaut-Marlangue, J. Moreau, and Y. Ben Ari. Apoptosis associated DNA fragmentation in epileptic brain damage. Neuroreport 5:1053-1055 (1994).
4. Sloviter, R. S., E. Dean, and S. Neubort. Electron microscopic analysis of adrenalectomy-induced hippocampal granule cell degeneration in the rat: apoptosis in the adult central nervous system. J Comp. Neurol. 330:337-351 (1993).
5. Gold, R., M. Schmied, G. Giegerich, and H. Breitschopf. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 71:219-225 (1994).
6. Su, J. H., A. J. Anderson, B. J. Cummings, and C. W. Cotman. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5:2529-2533 (1994).
7. Olanow, C. W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:439-444 (1993).
8. Adams, J. D., and I. N. Odunze. Oxygen free radicals and Parkinson's disease. Free Radical Biol. Med. 10:161-169 (1991).
9. Hirsch, E. C. Does oxidative stress participate in nerve cell death in Parkinson's disease? Eur. Neurol. 33(Suppl. 1):52-59 (1993).
10. De Vito, M. J., and G. C. Wagner. Methamphetamine-induced neuronal damage a possible role for free radicals. Neuropharmacol. 28:1145-1150 (1989).
11. Cohen, G., and R. E. Heikkila. The generation of hydrogen peroxide, superoxide radical and hydroxy radical by 6-hydroxydopamine, dialuric acid and related cytotoxic agents. J. Biol. Chem. 249:2447-2452 (1974).
12. Gibb, J. W., M. Johnson, D. M. Stone, and G. R. Hanson. Mechanisms mediating biogenic amine deficits induced by amphetamine and its congeners. Nat. Inst. Drug Abuse Res. Monogr. 136:226 (1993).
13. Louis, J.-C., E. Magal, and S. Varon. Receptor-mediated toxicity of norepinephrine on cultured catecholaminergic neurons of the rat brain stem. J. Pharmacol. Exp. Ther. 262:1274-1283 (1992).
14. Michel, P. P., and F. Hefti. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26:428-435 (1990).
15. Mytilineou, C., S.-K. Han, and G. Cohen. Toxic and protective effects of L-DOPA on mesencephalic cell cultures. J. Neurochem. 61:1470-1478 (1993).
16. Suri, C., B. P. Fung, A. S. Tischler, and D. M. Chikaraishi. Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice. J. Neurosci. 13:1280-1291 (1993).
17. Deckwerth, T. L., and E. M. Johnson, Jr. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J, Cell. Biol. 123:1207-1222 (1993).
18. De, A., N. I. Boyadjieva, M. Pastorcic, B. V. Reddy, and D. K. Sarkar. Cyclic AMP and ethanol interact to control apoptosis and differentiation in hypothalamic beta-endorphin neurons. J. Biol. Chem. 269:26697-26705 (1994).
19. D'Mello, S. R., C. Galli, T. Ciotti, and P. Caslissano. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. USA 90: 10989-10993 (1993).
20. Hockenbery, D. M., A. N. Oltvai, X-M Yin, C. L. Milliman, and S. J. Korsmeyer. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251 (1993).
21. Kane, D. J., T. A. Sarafian, R. Anton, H. Hahn, E. B. Gralla, J. S. Valentine, T. Ord, and D. E. Bredesen. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science (Washington D. C.) 262:1274-1277 (1993).
22. Jonsson, G. Quantitation of fluorescence of biogenic monoamines. Prog. Histochem. Cytochem. 2:299-344 (1971).
23. Beaudet, A., and L. Descarries. Fine structure of monoamine axon terminals in cerebral cortex, in Monoamine Innervation of Cerebral Cortex (L. Descarries, T. R. Reader, and H. H. Jasper, eds.). Liss, New York, 109-127 (1984).
24. Madison, D. V., and R. A. Nicoll. Noradrenalin blocks accommodation of pyramidal cell discharge in the hippocampus. Nature (Lond.) 299:636-638 (1982).
25. Baker, A. J., M. H. Zornow, M. S. Scheller, T. L. Yaksh, S. R. Skilling, D. H. Smulli, A. A. Larson, and R. Kuczenski. Changes in extracellular concentrations of glutamate, aspartate, glycine, dopamine, serotonin and dopamine metabolites after transient global ischemia in the rabbit brain. J. Neurochem. 57:1370-1379 (1991).
26. Akiyama, Y., K. Koshimura, T. Ohue, K. Lee, S. Miwa, S. Yamagata, and H. Kikuchi. Effects of hypoxia on the activity of the dopaminergic neuron system in the rat striatum as studied by in vivo brain microdialysis. J. Neurochem. 57:997-1002 (1991).
27. Graham, D. G. Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology 5:83-96 (1984).
28. Lennon, S. V., S. J. Martin, and T. G. Cotter. Dose-dependent induction of apoptosis in human tumor cell lines by widely diverging stimuli. Cell Prolif. 24:203-214 (1991).
29. Whittemore, E. R., D. T. Loo, and C. W. Cotman. Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons. Neuroreport 5:1486-1488 (1994).
30. Ambani, L. M., M. H. Van Woert, and S. Murphy. Brain peroxidase and catalase in Parkinson disease. Arch. Neurol. 32:114-118 (1975).
31. Perry, T. L., D. V. Godin, and S. Hansen. Parkinaon's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33:305-310 (1982).
32. Hockenbery, D. M., M. Zutter, W. Hickey, M. Nahm, and S. J. Korsmeyer. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA 88:6961-6965 (1991).
33. Abe-Dkohmae, S., N. Harada, D. Yamada, and R. Tanaka. Bcl-2 gene is highly expressed during neurogenesis in the central nervous system. Biochem. Biophys. Res. Commun. 191:915-921 (1993).
34. Mah, S. P., T. Zhong, Y. Liu, A. Roghani, R. H. Edwards, and D. E. Bredesen. The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J. Neurochem. 60:1183-1186 (1993).
35. Allaopp, T. E., S. Wyatt, H. F. Paterson, and A. M. Davies. The protooncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73:295-307 (1993).
36. Martinou, J. C., M. Dubois-Dauphin, J. K. Staple, I. Rodriquez, H. Frankowski, M. Missotten, P. Alabertini, D. Talabot, S. Catsicas, C. Pietra, and J. Huarte. Overexpression of Bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13:1017-1030 (1994).
37. Dubois-Dauphin, M., H. Frankowski, Y. Tsujimoto, J. Huarte, and J. C. Martinou. Neonatal motor neurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc. Natl. Acad. Sci. USA 91:3309-3313 (1994).
38. Keith, F. J., D. A. Bradbury, Y.-M. Zhu, and N. H. Russell. Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C. Leukemia 9:131-138 (1995).
39. Kitada, S., T. Miyashita, S. Tanaka, and J. C. Reed. Investigations of antisense oligonucleotides targeted against bcl-2 RNAs. Antisense Res. Dev. 3:157-169 (1993).